Bumrungrad Hospital Public Co., Ltd.

Bumrungrad Hospital Public Co., Ltd.'s next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Bumrungrad Hospital Public Co., Ltd. has 79.43M shares outstanding.

As of June 30, 2026, Bumrungrad Hospital Public Co., Ltd. maintains a current ratio of 3.36, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.36, indicating conservative leverage, while an interest coverage ratio of 2,009.80 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Bumrungrad Hospital Public Co., Ltd. posted a return on equity (ROE) of 27.13, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 25.72 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 22.71, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 26.55, useful for judging operating efficiency across full business cycles. The company generates approximately 172,128.88 in revenue per employee across its workforce of 4,463.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 39.73 indicates how many times Bumrungrad Hospital Public Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Bumrungrad Hospital Public Co., Ltd. recorded 53.07M in income tax expense. That works out to an effective tax rate of 18.73, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 283.32M, leaving 228.71M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on August 18, 2026, Bumrungrad Hospital Public Co., Ltd.'s stock has gained approximately 7.24% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Bumrungrad Hospital Public Co., Ltd. generated 768.21M in revenue and converted that into 228.71M in net income, yielding earnings per share of 2.66. EBITDA reached 310.83M, while operating income came in at 277.16M.

As of June 30, 2026, Bumrungrad Hospital Public Co., Ltd. holds 227.68M in cash and equivalents against 3.00M in total debt, resulting in a net debt position of -116.85M. Total book value stands at 823.93M, with working capital of 302.03M providing operational flexibility.

Bumrungrad Hospital Public Co., Ltd. produced 211.75M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -82.60M in capital expenditures, free cash flow totaled 129.15M - equivalent to 1.63 per share.

Over the twelve months ended June 30, 2026, Bumrungrad Hospital Public Co., Ltd. posted a gross margin of 51.98, reflecting its pricing power and cost economics. The operating margin of 36.08 and net profit margin of 29.77 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Bumrungrad Hospital Public Co., Ltd. paid dividends of 3.31 per share. The dividend payout ratio of 113.53 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.